278 related articles for article (PubMed ID: 33081543)
1. Current perspectives on inhibitory SMAD7 in health and disease.
de Ceuninck van Capelle C; Spit M; Ten Dijke P
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):691-715. PubMed ID: 33081543
[TBL] [Abstract][Full Text] [Related]
2. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
[TBL] [Abstract][Full Text] [Related]
3. Regulation of TGF-beta signaling by Smad7.
Yan X; Liu Z; Chen Y
Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):263-72. PubMed ID: 19352540
[TBL] [Abstract][Full Text] [Related]
4. Itch E3 ubiquitin ligase positively regulates TGF-β signaling to EMT via Smad7 ubiquitination.
Park SH; Jung EH; Kim GY; Kim BC; Lim JH; Woo CH
Mol Cells; 2015 Jan; 38(1):20-5. PubMed ID: 25518932
[TBL] [Abstract][Full Text] [Related]
5. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory Smad7: emerging roles in health and disease.
Briones-Orta MA; Tecalco-Cruz AC; Sosa-Garrocho M; Caligaris C; Macías-Silva M
Curr Mol Pharmacol; 2011 Jun; 4(2):141-53. PubMed ID: 21222648
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for inhibitory effects of Smad7 on TGF-β family signaling.
Murayama K; Kato-Murayama M; Itoh Y; Miyazono K; Miyazawa K; Shirouzu M
J Struct Biol; 2020 Dec; 212(3):107661. PubMed ID: 33166654
[TBL] [Abstract][Full Text] [Related]
8. SMAD7: a timer of tumor progression targeting TGF-β signaling.
Luo L; Li N; Lv N; Huang D
Tumour Biol; 2014 Sep; 35(9):8379-85. PubMed ID: 24935472
[TBL] [Abstract][Full Text] [Related]
9. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
10. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
11. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
[TBL] [Abstract][Full Text] [Related]
12. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation.
Li Y; Cui C; Xie F; Kiełbasa S; Mei H; van Dinther M; van Dam H; Bauer A; Zhang L; Ten Dijke P
J Mol Cell Biol; 2020 Feb; 12(2):138-151. PubMed ID: 31291647
[TBL] [Abstract][Full Text] [Related]
13. Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis.
Liu FY; Li XZ; Peng YM; Liu H; Liu YH
Am J Nephrol; 2007; 27(2):176-83. PubMed ID: 17347560
[TBL] [Abstract][Full Text] [Related]
14. Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.
Yan X; Chen YG
Biochem J; 2011 Feb; 434(1):1-10. PubMed ID: 21269274
[TBL] [Abstract][Full Text] [Related]
15. USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.
Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
EMBO Rep; 2017 May; 18(5):797-808. PubMed ID: 28381482
[TBL] [Abstract][Full Text] [Related]
16. TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.
Yan X; Zhang J; Pan L; Wang P; Xue H; Zhang L; Gao X; Zhao X; Ning Y; Chen YG
Mol Cell Biol; 2011 Sep; 31(18):3700-9. PubMed ID: 21791611
[TBL] [Abstract][Full Text] [Related]
17. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A
J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939
[TBL] [Abstract][Full Text] [Related]
18. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
20. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
